LEVERaging RNA regulatory mechanisms to drug the undruggable with RNA-targeted therapeutics. We identify novel target RNA biology and design targeted therapeutics to increase, inhibit or restore expression/protein function. We currently have 4 programs in CNS and related disease areas, with the lead program (L5001) going into IND in 2025.

Leverna Therapeutics

Co-Founder, President & CSO/COO

Co-Founder & President

Executive Director, Head of Biology (FUSION BioVenture)

Director, Head of Biology (FUSION BioVenture)

Senior Scientist, Cell and Molecular Biology Team Lead

Scientist, Translational Systems Biology Group (TSB) Lab Lead

Postdoctoral Research Scientist

Director of Investor Relations

Director of Strategy and Portfolio Management

Associate

Strategic Planning Manager

Director, Phamacology

Senior Principal Scientist

Principal Scientist

Associate Principal Scientist

Senior Scientist

Research Scientist

Associate Research Scientist

Leverna Therapeutics - Founder and Chair of Board of Directors

Chair of the Board of Directors

Consultant and Senior Advisor

Entrepreneur-in-Residence

Vice President, Biology and Preclinical Research and Development

Vice President, Discovery Research

Executive Director

Director, Molecular and Cellular Pharmacology

Sr Scientist/Associate Director

Principal Scientist, Bioinformatics

Associate Principal Scientist, Bioinformatics

Senior Bioinformatics Scientist

Bioinformatics Scientist

Graduate Research Assistant

Undergraduate Research Assistant

Undergraduate Peer Mentor

Head of RNA Targeting Platform

Sr. Scientist

Sr. Research Biologist

Postdoctoral Fellow

Postdoctoral Research Associate

Postdoctoral Research Fellow

Outlook

Varnish

Archimmune Therapeutics Inc.

President, Head of R&D

Senior Vice President, Early Development

Principal & founder

Venture Partner

Executive Director, Translational Sciences | Head of Clinical Development

Associate Director, Project & Portfolio Management

Founding Scientist, Project Leader

Sr. Principal Investigator

Scientist II

Vice President, Head of CMC

Group Head, Distinguished Scientist, Non-viral Gene Therapy, Genomic Medicine Unit

Vice President Of Process Sciences and Manufacturing

Senior Director of Research and Development

VP of Process Sciences and Manufacturing

Associate Director Of Development

Scientist

Specialist

Associate Specialist

Research Assistant

Teaching Assistant

Vice Chair of Translational Research and Commercialization, Professor with Tenure

A. Kenneth Pye Professorship in Cancer Research

Cofounder and board member

Co-Founder and Acting CEO

Associate Editor

Chief Scientific Officer

Managing Director

Vice President of Strategy and Business Development

CEO and Director of the Board

Executive Director, Discovery Biology

Senior Director, Discovery Biology

Senior Group Leader, Research

HHMI Postdoctoral Fellow

Senior Data Analyst

Data Analyst

Deposition Scientist

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group. Fosun Pharma directly operates businesses including pharmaceuticals, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.Fosun Pharma is patient-centered and clinical needs-oriented. The company continuously enriches its innovative product pipeline through independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma improves the research and clinical development capabilities of FIC (First-in-class) and BIC (Best-in-class) new drugs as well as accelerates the R&D and launch of innovative technologies and products. Fosun Pharma's innovative products mainly covered core therapeutic areas such as tumors (solid tumors and hematologic tumors), immunology, central nervous system, and chronic diseases (liver disease/metabolism/kidney disease).Guided by the 4IN strategy (Innovation, Internationalization, Intelligentization, and Integration), Fosun Pharma will uphold the development model of "Innovation Transformation, Integrated Operation and Steady Growth", with the mission of creating shareholder values through strengthening its independent R&D and external cooperation and enriching its product pipelines, as well as promoting the global networks and enhancing operational efficiency. Fosun Pharma will actively promote the digital and physical business layout in the pharmaceutical and healthcare industry and is committed to becoming a first-class enterprise in the global pharmaceutical and healthcare markets.

Fosun Pharma

EHS Supervisor

EHS MT

先博生物 临床运营部负责人

Clinical Operation Head

Associate Director Of Clinical Operations

Global Studies Manager/Lead

Country Study Manager

Senior Clinical Trial Monitor

Clinical Trial Monitor

Director Of Business Development

Associate Director Business Development

Consultant

Senior Marketing Engineer

Application Engineer

Industrial Engineer

HRBP

Senior Director Human Resources

Compensation Benefits Expert

Talents consultant

Benefit consultant

Senior Director of Talents Acquisition

Senior HRBP Manager

Senior Recruitment Manager

Recruitment Manager

EHS Director

EHS Consultant(Project based)

EHS Manager

Research Specialist

Investment Analyst/投资分析师

Summer Investment Analyst

Visiteur médical

Clinicien sur un programme de recherche sur le paludisme (ICEMR)

Marketing Manager

Ecosystem Lead

Product Specialist

Head Of R&D strategy & portfolio management, GPL of original preclinical projects

Head of medical operations

Head of Medical Planning & Effectiveness and Innovation

Director of Pharma Insights & Principal of Management Consulting

Head of Bio-Pharmaceutical Consulting

Director, Consulting

Early R&D Project Development Manager

Intern, Strategic Assessment & Planning

Medical Advise Manager

Mobile Friendly

Baidu Ads

ASP.NET

Microsoft-IIS

Atlas Venture is a leading biotech venture capital firm. With the goal of doing well by doing good, we have been building breakthrough biotech startups since 1993. We work side by side with exceptional scientists and entrepreneurs to translate high impact science into medicines for patients. Our seed-led venture creation strategy rigorously selects and focuses investment on the most compelling opportunities to build scalable businesses and realize value. 

Lijun Wu

Leverna Therapeutics - Founder and Chair of Board of Directors at Leverna Therapeutics

Lijun Wu's Professional Contact Details

Lijun Wu's Current Company Details

Leverna Therapeutics

Lijun Wu's Work History and Education

Others Named Lijun Wu

Frequently Asked Questions about Lijun Wu

What company does Lijun Wu work for?

What is Lijun Wu's role at Leverna Therapeutics?

What is Lijun Wu's email address?

What is Lijun Wu's business email address?

What is Lijun Wu's direct mobile number?

What industry does Lijun Wu work in?

Who are Lijun Wu's colleagues?

Colleagues at Leverna Therapeutics

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?